Kit for combined detection of acute myeloid leukemia
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 苏州科贝生物技术有限公司
- Publication Date
- 2020-12-18
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of molecular biological detection, in particular to a kit for combined detection of acute myeloid leukemia. Background technique
[0002] Acute myeloid leukemia (AML) is a malignant disease of myeloid hematopoietic stem cells. It is mainly characterized by abnormal proliferation of primitive and immature myeloid cells in bone marrow and peripheral blood. The clinical manifestations are anemia, hemorrhage, infection and fever, visceral infiltration, abnormal metabolism, etc. Most cases are acute and severe, and the prognosis is dire.
[0003] In recent years, through the study of gene mutation frequency and some susceptibility biomarkers, it has been found that acute myeloid leukemia may be the result of a combination of genetics and environmental factors. Acute myeloid leukemia (AML) is a heterogeneous disease comprising many entities with distinct genetic abnormalities and clinical features.
[0004] Studying the g...